Childhood cancer research in danger

Long-term funding and better collaboration needed to maintain improvements in survival, report says

2011-02-09

(Press-News.org) At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today*. The authors also looked at the citation impact of paediatric oncology papers and found that childhood cancer research is once again the poor relation; unlike cancer papers in general, paediatric oncology papers received fewer citations than the average for the journals in which they were published.

"Working in this kind of discouraging environment makes the achievements of childhood cancer research all the more praiseworthy", said Professor Richard Sullivan, from the Centre for Global OncoPolicy, London, UK, and one of the authors of the report. "About 80% of all childhood cancer patients now survive, due to massive improvements in diagnosis and treatment over the last forty years."

'The State of Research into Children with Cancer across Europe – New Policies for a New Decade' is published by the European Society for Paediatric Oncology (SIOPE) and the Centre for Global OncoPolicy. The report will be presented today ( Wednesday 9 February) at a special event in the European Parliament to mark International Childhood Cancer Awareness Day to a wide range of EU policymakers as well as young cancer patients and parents. The authors set out to look at the current state of paediatric oncology research in Europe.

They found that countries with a larger oncology burden, such as those in Eastern Europe, tended not to collaborate in research with those with a better-developed research structure, and this in turn affected the care they were able to give young patients. "Paediatric oncologists from ten countries were asked about their national situations and the differences were striking", said Professor Kathy Pritchard-Jones, Cancer Programme Director at the UCL Institute of Child Health, London, UK and Past President of SIOPE. "For example, a respondent from Bosnia-Herzegovina cited lack of hospital space, no specialist paediatric oncology radiologists, and inadequate diagnostic facilities, with everything adapted to adult patients. The Czech Republic said that research grants were usually for only three years and there was little support for young scientists to attend international courses and congresses which could help harmonise the level of knowledge across European states."

In Italy, it was the fragmentation of childhood cancer care which concerned doctors, with nearly 50 centres specialising in paediatric haematology and oncology, and a lack of co-ordination between research laboratories and clinics. In comparison, Sweden has only six paediatric oncology units, which work closely together but, even there, there are problems of funding and a lack of experienced staff. The UK expressed concern about the effects of health service cuts on children's cancer care, and the fact that infrastructure changes had moved paediatrics alongside the adult cancer model, meaning that research for children now has to compete for funds at a much more visible level with research for adults.

The authors also found large differences in the provision of information on childhood cancer, with variations in the involvement of parental organisations, the use of digital media, and the adoption of a common national standard for information provision. "When a child is sick, the provision of accurate information to the patient and family is essential" said Professor Sullivan. "We believe that the establishment of a European Common Information Portal could do much to tackle major deficiencies in information in countries with few or no patient organisations, or where the existence of a large number of languages make access to such information difficult."

The authors call for adequate long-term EU funding to support a Europe-wide clinical trials network for paediatric oncology. "This is an essential prerequisite for the effective testing and dissemination of new therapies and techniques", said Professor Pritchard-Jones. "We also need to study treatment outcomes, and for this the creation of a European Childhood Cancer Epidemiological Registry is essential. With these tools we can maintain the enormous progress that has been made in the past. Without them, we run the risk of jeopardising that progress and failing children who are dependent on us for their survival."

### *Sullivan R, Pritchard-Jones K, Camporesi S, Lewison G, Vassal G, Ladenstein R, et al. (2011) The state of research into children with cancer across Europe: new policies for a new decade ecancer Vol 5 doi: 10.3332/ecancer.2011.210

ELSE PRESS RELEASES FROM THIS DATE:

Using pharmacist-directed service improves quality of care for patients

2011-02-09

DETROIT ¬– A Henry Ford Hospital study has found that a pharmacist-directed anticoagulation service improves the way medication is managed for patients with heparin-induced thrombocytopenia (HIT), a common but life-threatening thromboembolic disorder. Researchers found that patients treated by the anticoagulation service had a favorable response to alternative anticoagulant drugs three times faster and were 32 percent more likely to receive proper dosage than patients who were treated with the same drugs by the patient's primary medical team. This is the first time ...

Increased levels of cardiac enzymes after heart bypass associated with increased mortality

2011-02-09

Researchers at Mount Sinai School of Medicine have found that even small amounts of damage to heart muscle during coronary artery bypass grafting (CABG) is associated with an increased risk of death, even among patients who initially do well following surgery. The study is published in the February 9 issue of the Journal of the American Medical Association (JAMA). Small elevations of troponin and creatine phosphokkinase – chemicals called enzymes that are released by heart muscle cells when they are damaged – have often been dismissed as unimportant. But Mount Sinai ...

Polar bear births could plummet with climate change

2011-02-09

University of Alberta researchers Péter Molnár, Andrew Derocher and Mark Lewis studied the reproductive ecology of polar bears in Hudson Bay and have linked declining litter sizes with loss of sea ice. The researchers say projected reductions in the number of newborn cubs is a significant threat to the western Hudson Bay polar-bear population, and if climate change continues unabated the viability of the species across much of the Arctic will be in question. Using data collected since the 1990s researchers looked at the changing length of time Hudson Bay is frozen ...

Turning bacteria against themselves

2011-02-09

Bacteria often attack with toxins designed to hijack or even kill host cells. To avoid self-destruction, bacteria have ways of protecting themselves from their own toxins. Now, researchers at Washington University School of Medicine in St. Louis have described one of these protective mechanisms, potentially paving the way for new classes of antibiotics that cause the bacteria's toxins to turn on themselves. Scientists determined the structures of a toxin and its antitoxin in Streptococcus pyogenes, common bacteria that cause infections ranging from strep throat to life-threatening ...

Speedy generic approval may not benefit consumers as much as expected, Rotman model shows

2011-02-09

Toronto – Faster approval times for generic drugs will get them into consumers' hands quicker, but may not make the price any better, a pricing and marketing researcher has found. A mathematical model created by Andrew Ching shows that fewer firms enter the marketplace because the chances of getting there first and commanding the best profits are dramatically smaller when drug approval times are shorter. Ching is an associate professor of marketing at the University of Toronto's Rotman School of Management. Using the drug clonidine, Prof. Ching's model showed the number ...

Combining brain imaging, genetic analysis may help identify people at early risk of Alzheimer's

2011-02-09

For Immediate Release – February 8, 2011 - (Toronto) – A new study from the Centre for Addiction and Mental Health (CAMH) has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for over 90% of Alzheimer's cases. This innovative study has combined genetics and brain imaging to determine who may be at risk for developing late-onset Alzheimer's disease long before symptoms appear. The gene, which is called brain-derived neurotrophic factor (BDNF), is crucial to maintaining healthy function of ...

Eggs are now naturally lower in cholesterol

2011-02-09

Park Ridge, IL (February 8, 2011) – According to new nutrition data from the United States Department of Agriculture's Agricultural Research Service (USDA-ARS), eggs are lower in cholesterol than previously thought. The USDA-ARS recently reviewed the nutrient composition of standard large eggs, and results show the average amount of cholesterol in one large egg is 185 mg, 14 percent lower than previously recorded. The analysis also revealed that large eggs now contain 41 IU of vitamin D, an increase of 64 percent. "We collected a random sample of regular large shell eggs ...

Single-cell marine predator's unique survival mechanisms revealed: UBC research

2011-02-09

University of British Columbia researchers have uncovered the unique survival mechanisms of a marine organism that may be tiny, but in some ways has surpassed sharks in its predatory efficiency. Published today in the journal Nature Communications, the research team's portrait of the microscopic dinoflagellate Oxyrrhis marina reveals a predator so efficient that it has even acquired a gene from its prey. NB: A microscopic photo of Oxyrrhis marina is available at http://www.publicaffairs.ubc.ca/?p=17636. "It's an interesting case of Lateral Gene Transfer, or the movement ...

Hope for stroke victims

2011-02-09

Much of the devastation of stroke and head trauma is due to damage caused the overproduction of a substance in the brain called glutamate. Preventing this damage has been impossible, until now, as many drugs don't cross the so-called blood-brain barrier, and those that do often don't work as intended. But a method originally devised at the Weizmann Institute of Science may, in the future, offer a way to avert such glutamate-induced harm. Prof. Vivian I. Teichberg of the Institute's Neurobiology Department first demonstrated a possible way around these problems in 2003. ...

Turning off stress

2011-02-09

Post-traumatic stress disorder can affect soldiers after combat or ordinary people who have undergone harrowing experiences. Of course, feelings of anxiety are normal and even desirable – they are part of what helps us survive in a world of real threats. But no less crucial is the return to normal – the slowing of the heartbeat and relaxation of tension – after the threat has passed. People who have a hard time "turning off" their stress response are candidates for post-traumatic stress syndrome, as well as anorexia, anxiety disorders and depression. How does the body ...

Childhood cancer research in danger

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: